Your search for

235 results were returned

  1. Twobirds news
    30 May 2019
    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
    www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

  2. Twobirds news
    24 May 2019
    Bird & Bird advises FUJIFILM on the 100% acquisition of medwork
    www.twobirds.com/en/news/press-releases/2019/germany/bird-and-bird-advises-fujifilm-on-the-100-acquisition-of-medwork

    International law firm Bird & Bird advises the FUJIFILM group on the acquisition of German medwork GmbH, a company that develops, manufactures and markets instruments for therapeutic and diagnostic endoscopy

  3. Twobirds news
    05 April 2019
    Bird & Bird advises Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in Vakzine Projekt Management GmbH
    www.twobirds.com/en/news/press-releases/2019/germany/bird-and-bird-advises-serum-institute-of-india-pvt-ltd-on-the

    International law firm Bird & Bird advises Indian vaccine manufacturer Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in German project management service provider Vakzine Projekt Management ...

  4. Legal news
    24 January 2020
    Brexit: Medical devices implications
    www.twobirds.com/en/news/articles/2016/uk/brexit-medical-devices-implications

    The UK exits the EU on 31st January 2020. By virtue of the transition period in the Withdrawal Agreement, EU law will continue to apply in and in relation to the UK only until the 31st December 2020.